CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- 4 Open-market buy Director bought 3,605 shares at $4.49 ($16,186)
- 4 Open-market buy Director bought 4,320 shares at $4.88 ($21,082)
- 4 Open-market buy Chief Financial Officer bought 2,113 shares at $4.75 ($10,037)
- 4 Open-market buy Director bought 3,016 shares at $4.55 ($13,723)
- 4 Open-market buy Chief Financial Officer bought 3,000 shares at $6.76 ($20,280)
- 4 Exercise or conversion Chief Financial Officer acquired 3,605 shares (option exercise)
- 4 Planned sale General Counsel and Secretary sold 588 shares at $8.19 ($4,816)
- 4 Open-market sale President and CEO sold 3,012 shares at $8.19 ($24,668)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale General Counsel and Secretary sold 93 shares at $11.79 ($1,096)
- 4 Exercise or conversion Chief Financial Officer acquired 454 shares (option exercise)
- 4 Open-market sale Chief Research Officer sold 50 shares at $11.79 ($590)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 14 · 269 filings